North Africa Generic Drug Market

North Africa Generic Drug Market Report, Industry Overview, Growth Rate and Forecast 2021-2026

According to IMARC Group’s latest report, titled “North Africa Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the North Africa Generic drug market is currently witnessing strong growth in 2020. A generic drug refers to a pharmaceutical medication that has the same active pharmaceutical ingredients (APIs) as a branded drug. It is developed after the expiration of the patent on the original drug and is identical to it in terms of dosage, quality, strength, efficiency, performance, etc. Generic drugs are usually available in the oral, dermal, injectables, and inhalable variants. They are extensively utilized in the cost-effective treatment of cardiovascular diseases (CVDs), diabetes, respiratory disorders, etc. Generic drugs are widely used in pharmacies and hospitals across North Africa.

Request for a PDF sample of this report

The rising prevalence of chronic medical diseases and the escalating need for affordable treatment options are some of the primary factors driving the North Africa generic drug market. In addition to this, several favorable initiatives by government bodies aimed at promoting domestic drug manufacturing are further stimulating the market growth. Moreover, numerous branded drugs are nearing their expiration dates, which is also catalyzing the North Africa generic drug market. Besides this, the introduction of biosimilar drugs and formulations in the market is acting as another significant growth-inducing factor. Furthermore, the emerging trend of collaborations between hospitals, government bodies, and philanthropies to address drug shortages by investing in generic drug companies is also positively influencing the market growth. Apart from this, the launch of re-innovated generics with reduced hypersensitivity and intra- and inter-patient variability is anticipated to fuel the North Africa generic drug market over the forecasted period. Looking forward, the market is expected to continue its strong growth during the forecast period (2021-2026)

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Market Segmentation:

Breakup by Segment:

  • Unbranded Generics
  • Branded Generics

Breakup by Therapy Area:

  • Central Nervous System
  • Cardiovascular
  • Dermatology
  • Genitourinary/Hormonal
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Others

Breakup by Drug Delivery:

  • Oral
  • Injectables
  • Dermal/Topical
  • Inhalers

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies

Breakup by Country:

  • Algeria
  • Egypt
  • Libya
  • Morocco
  • Tunisia
  • Others

Ask Analyst for Customization and Explore full report with TOC & List of Figures:

We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:      

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • Market Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Value Chain Analysis
  • Structure of the Global Market
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:


30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: [email protected]

Tel No:(D) +91 120 433 0800

Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Leave a Reply

Your email address will not be published. Required fields are marked *